KR101992282B1 - 불활성화된 rgd 도메인을 갖는 변형된 오스테오폰틴 펩티드 및 이의 용도 - Google Patents
불활성화된 rgd 도메인을 갖는 변형된 오스테오폰틴 펩티드 및 이의 용도 Download PDFInfo
- Publication number
- KR101992282B1 KR101992282B1 KR1020147006108A KR20147006108A KR101992282B1 KR 101992282 B1 KR101992282 B1 KR 101992282B1 KR 1020147006108 A KR1020147006108 A KR 1020147006108A KR 20147006108 A KR20147006108 A KR 20147006108A KR 101992282 B1 KR101992282 B1 KR 101992282B1
- Authority
- KR
- South Korea
- Prior art keywords
- delete delete
- seq
- amino acid
- asp
- preferred
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/18—Materials or treatment for tissue regeneration for hair reconstruction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Birds (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1113770.0A GB2493540A (en) | 2011-08-10 | 2011-08-10 | Agents for stimulating hair growth in mammals |
| GB1113770.0 | 2011-08-10 | ||
| PCT/GB2012/051955 WO2013021212A2 (en) | 2011-08-10 | 2012-08-10 | Novel compositions and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20140083977A KR20140083977A (ko) | 2014-07-04 |
| KR101992282B1 true KR101992282B1 (ko) | 2019-06-24 |
Family
ID=44735704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020147006108A Active KR101992282B1 (ko) | 2011-08-10 | 2012-08-10 | 불활성화된 rgd 도메인을 갖는 변형된 오스테오폰틴 펩티드 및 이의 용도 |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US9381149B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2741761B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6049718B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101992282B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN103930125B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2012293448B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112014003051B1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2844749C (cg-RX-API-DMAC7.html) |
| DK (2) | DK2741761T3 (cg-RX-API-DMAC7.html) |
| ES (2) | ES2740826T3 (cg-RX-API-DMAC7.html) |
| GB (1) | GB2493540A (cg-RX-API-DMAC7.html) |
| PL (2) | PL2741761T3 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2604797C2 (cg-RX-API-DMAC7.html) |
| TR (1) | TR201910685T4 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013021212A2 (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190141923A (ko) * | 2018-06-15 | 2019-12-26 | 인하대학교 산학협력단 | 오스테오폰틴 단백질 단편을 유효성분으로 함유하는 뇌손상 예방 또는 치료용 약학 조성물 |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2493540A (en) | 2011-08-10 | 2013-02-13 | Follicum Ab | Agents for stimulating hair growth in mammals |
| GB201406989D0 (en) * | 2014-04-17 | 2014-06-04 | Follicum Ab | Novel treatments |
| JP6548126B2 (ja) * | 2014-11-27 | 2019-07-24 | 国立大学法人大阪大学 | Iii型コラーゲン産生促進剤 |
| KR101906557B1 (ko) * | 2015-08-06 | 2018-10-11 | 서울대학교산학협력단 | 합성 펩타이드를 이용한 유도만능줄기세포의 제조방법 |
| EP3600108A4 (en) * | 2017-03-23 | 2021-01-06 | The Regents of the University of California | STIMULATION OF HAIR GROWTH BY SENESCENCE CELLS AND SENESCENCE-ASSOCIATED SECRETORIC PHENOTYPE |
| AU2018262805B2 (en) * | 2017-05-04 | 2022-02-17 | Follicum Ab | Peptides for treatment of diabetes |
| US20220002343A1 (en) * | 2018-11-07 | 2022-01-06 | Follicum Ab | Peptide fragments for treatment of diabetes |
| US20220273765A1 (en) * | 2019-04-24 | 2022-09-01 | Follicum Ab | Topical formulation |
| EP4110461A4 (en) * | 2020-02-25 | 2024-05-01 | Amplifica, Inc. | COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH |
| AU2022335599A1 (en) * | 2021-08-25 | 2024-03-07 | Amplifica Holdings Group, Inc. | Compositions and methods for stimulating hair growth |
| WO2023218095A1 (en) * | 2022-05-13 | 2023-11-16 | Coegin Pharma Ab | Agents for stimulating tissue regeneration |
| CN119300852A (zh) * | 2022-05-13 | 2025-01-10 | 科京制药公司 | 诱导血管形成的药剂 |
| AU2024311323C1 (en) * | 2023-06-20 | 2026-06-11 | Amplifica Holdings Group, Inc. | Compositions and methods for stimulating hair growth |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001084159A2 (en) * | 2000-05-01 | 2001-11-08 | Board Of Regents, The University Of Texas System | Ldl receptor signaling pathways |
| WO2005066339A2 (en) * | 2004-01-06 | 2005-07-21 | Novozymes A/S | Polypeptides of alicyclobacillus sp. |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE459005B (sv) | 1985-07-12 | 1989-05-29 | Aake Rikard Lindahl | Saett att framstaella sfaeriska polymerpartiklar |
| US5643872A (en) | 1989-10-23 | 1997-07-01 | Smithkline Beecham Corporation | Cyclic anti-aggregatory peptides |
| US5756094A (en) | 1991-03-27 | 1998-05-26 | Trustees Of The University Of Pennsylvania | Methods for stimulating follicular growth |
| US5753612A (en) | 1992-10-27 | 1998-05-19 | Yissum Research Development Co. Of The Hebrew University Of Jerusalem | Pharmaceutical composition and method for inhibiting hair growth by administration of activin or activin agonists |
| US6008058A (en) | 1993-06-18 | 1999-12-28 | University Of Louisville | Cyclic peptide mixtures via side chain or backbone attachment and solid phase synthesis |
| EP0821592A4 (en) * | 1995-04-20 | 2000-03-01 | Univ Pennsylvania | COMPOSITIONS AND METHODS FOR REGULATING HAIR GROWTH |
| CA2192782C (en) | 1995-12-15 | 2008-10-14 | Nobuyuki Takechi | Production of microspheres |
| WO2001028509A1 (en) | 1999-10-21 | 2001-04-26 | Kao Corporation | Depilatories and agents for external use |
| EP1269196B1 (en) | 2000-03-23 | 2007-11-21 | Glaxo Group Limited | Method of screening for inhibitors of osteopontin |
| AU2002220920A1 (en) * | 2000-12-08 | 2002-06-18 | Oxford Biomedica (Uk) Limited | Method for identification of genes involved in specific diseases |
| PL366469A1 (en) | 2001-04-05 | 2005-02-07 | Immuno-Biological Laboratories Co, Ltd. | Anti-osteopontin antibody and use thereof |
| ES2387082T3 (es) * | 2001-05-17 | 2012-09-13 | Merck Serono Sa | Uso de OSTEOPONTINA para el tratamiento y/o prevención de enfermedades neurológicas |
| CN101665538A (zh) | 2003-12-18 | 2010-03-10 | 诺沃挪第克公司 | 与白蛋白样物质相连的新glp-1类似物 |
| AR048024A1 (es) * | 2004-03-05 | 2006-03-22 | Bayer Cropscience Gmbh | Plantas con actividad aumentada de distintas enzimas fosforilantes del almidon |
| RU2309730C2 (ru) * | 2006-04-18 | 2007-11-10 | Леонид Юрьевич Брежнев | Средство для стимуляции роста волос, его варианты и способ его получения |
| WO2008086449A2 (en) * | 2007-01-09 | 2008-07-17 | Oregon Health & Science University | Synthetic osteopontin peptides and methods of use |
| GB2493540A (en) | 2011-08-10 | 2013-02-13 | Follicum Ab | Agents for stimulating hair growth in mammals |
-
2011
- 2011-08-10 GB GB1113770.0A patent/GB2493540A/en not_active Withdrawn
-
2012
- 2012-08-10 DK DK12768879.4T patent/DK2741761T3/en active
- 2012-08-10 TR TR2019/10685T patent/TR201910685T4/tr unknown
- 2012-08-10 ES ES16169698T patent/ES2740826T3/es active Active
- 2012-08-10 EP EP12768879.4A patent/EP2741761B1/en active Active
- 2012-08-10 RU RU2014108819/10A patent/RU2604797C2/ru active
- 2012-08-10 ES ES12768879.4T patent/ES2576299T3/es active Active
- 2012-08-10 BR BR112014003051-0A patent/BR112014003051B1/pt active IP Right Grant
- 2012-08-10 US US14/237,108 patent/US9381149B2/en active Active
- 2012-08-10 PL PL12768879T patent/PL2741761T3/pl unknown
- 2012-08-10 CN CN201280049850.XA patent/CN103930125B/zh active Active
- 2012-08-10 AU AU2012293448A patent/AU2012293448B2/en active Active
- 2012-08-10 PL PL16169698T patent/PL3087999T3/pl unknown
- 2012-08-10 CA CA2844749A patent/CA2844749C/en active Active
- 2012-08-10 EP EP16169698.4A patent/EP3087999B1/en active Active
- 2012-08-10 JP JP2014524449A patent/JP6049718B2/ja active Active
- 2012-08-10 WO PCT/GB2012/051955 patent/WO2013021212A2/en not_active Ceased
- 2012-08-10 KR KR1020147006108A patent/KR101992282B1/ko active Active
- 2012-08-10 DK DK16169698.4T patent/DK3087999T3/da active
-
2016
- 2016-06-16 US US15/184,290 patent/US10137169B2/en active Active
-
2018
- 2018-10-31 US US16/176,201 patent/US10517932B2/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001084159A2 (en) * | 2000-05-01 | 2001-11-08 | Board Of Regents, The University Of Texas System | Ldl receptor signaling pathways |
| WO2005066339A2 (en) * | 2004-01-06 | 2005-07-21 | Novozymes A/S | Polypeptides of alicyclobacillus sp. |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190141923A (ko) * | 2018-06-15 | 2019-12-26 | 인하대학교 산학협력단 | 오스테오폰틴 단백질 단편을 유효성분으로 함유하는 뇌손상 예방 또는 치료용 약학 조성물 |
| KR102091567B1 (ko) | 2018-06-15 | 2020-03-20 | 인하대학교 산학협력단 | 오스테오폰틴 단백질 단편을 유효성분으로 함유하는 뇌손상 예방 또는 치료용 약학 조성물 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10517932B2 (en) | Compositions and uses thereof | |
| ES2281528T3 (es) | Peptidos eficaces en el tratamiento de tumores y otros estados que requieren la eliminacion o destruccion de celulas. | |
| AU2003210722A2 (en) | Bioactive keratin peptides | |
| AU2003210722A1 (en) | Bioactive keratin peptides | |
| CA2596597A1 (en) | Method for stimulation collagen synthesis and/or kgf expression | |
| EP3131528A1 (en) | Compositions comprising osteopontin derivatives for the inhibition of hair growth | |
| US9351914B2 (en) | Methods for modulating hair growth using truncated laminin-511 | |
| WO2007149938A2 (en) | Methods for promoting hair growth | |
| KR20140140396A (ko) | 피부 주름 개선 및 미백용 조성물 | |
| JP6548126B2 (ja) | Iii型コラーゲン産生促進剤 | |
| KR20140089295A (ko) | 피부 노화 개선용 조성물 | |
| HK1230068B (en) | Modified osteopontin peptides having an inactivated rgd domain and uses thereof | |
| HK1230068A1 (en) | Modified osteopontin peptides having an inactivated rgd domain and uses thereof | |
| KR101822633B1 (ko) | 폴리스타틴 유래 생리활성 펩타이드, 및 이의 용도 | |
| US8748568B2 (en) | Isolated A-type FHF N-terminal domain peptides and methods of use | |
| KR102077984B1 (ko) | 피부 주름 예방 및 개선용 조성물 | |
| HK1197540B (en) | Modified osteopontin peptides having an inactivated rgd domain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| A201 | Request for examination | ||
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U12-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| FPAY | Annual fee payment |
Payment date: 20220527 Year of fee payment: 4 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 5 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 6 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 7 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 8 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE) Year of fee payment: 8 |